Cary Street Partners Investment Advisory’s Cue Health Inc. Common Stock HLTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-490
Closed -$217 1857
2023
Q3
$217 Hold
490
﹤0.01% 1826
2023
Q2
$181 Hold
490
﹤0.01% 1718
2023
Q1
$892 Hold
490
﹤0.01% 1579
2022
Q4
$1.01K Buy
+490
New +$1.55K ﹤0.01% 1580

Other funds holding HLTH

Cary Street Partners Investment Advisory's HLTH Position: Q4 2023 in Review

Cary Street Partners Investment Advisory sold out of Cue Health Inc. Common Stock (HLTH) in Q4 2023, closing a stake of 490 shares — an estimated $217 sold.

Cary Street Partners Investment Advisory first reported a position in HLTH in Q4 2022 and held it in 4 quarters. The position peaked at $1.01K in Q4 2022. 63 funds tracked by Wall St. Rank hold HLTH as of Q4 2023.

  • Cary Street Partners Investment Advisory reported no remaining Cue Health Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Cary Street Partners Investment Advisory sold 490 Cue Health Inc. Common Stock shares in Q4 2023, an estimated $217.
  • Cary Street Partners Investment Advisory first reported a position in Cue Health Inc. Common Stock in Q4 2022 and held it in 4 quarters.
  • Cary Street Partners Investment Advisory's Cue Health Inc. Common Stock position peaked at $1.01K in Q4 2022.
  • 63 funds tracked by Wall St. Rank held Cue Health Inc. Common Stock as of Q4 2023.

Based on Cary Street Partners Investment Advisory's 13F filing for Q4 2023, filed 5 Feb 2024.